# A Pharmacodynamic Study With Ticagrelor in African American Patients

> **NCT01523392** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 50 (actual)

## Conditions studied

- Stable Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01523392
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523392, "A Pharmacodynamic Study With Ticagrelor in African American Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01523392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*